What is the immediate management for a patient in hypoglycaemic coma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hypoglycaemic Coma

For a patient in hypoglycaemic coma (unconscious, unable to follow commands, or seizing), immediately administer 10-20 grams of intravenous 50% dextrose, stop any insulin infusion if present, and if IV access is unavailable, give 1 mg intramuscular glucagon into the upper arm, thigh, or buttocks. 1, 2

Immediate Assessment and Treatment Algorithm

Step 1: Confirm Hypoglycemia and Assess Consciousness

  • Check blood glucose immediately to confirm diagnosis, but do not delay treatment if hypoglycemia is clinically suspected 1, 2
  • Assess the patient's level of consciousness and ability to swallow safely 1

Step 2: Treatment Based on Consciousness Level

For Unconscious/Comatose Patients (Cannot Follow Commands or Seizing):

  • Administer 10-20 grams of IV 50% dextrose immediately, titrated based on initial glucose value 1, 2
  • Stop any insulin infusion if present 1, 3
  • If no IV access is available: Give 1 mg glucagon intramuscularly into the upper arm, thigh, or buttocks 2, 4
    • For children weighing <25 kg or <6 years: Give 0.5 mg (0.5 mL) glucagon 4
  • Never attempt oral glucose in an unconscious patient due to aspiration risk 2

For Conscious Patients Who Can Swallow:

  • Administer 15-20 grams of oral glucose immediately (glucose tablets preferred) 5, 1, 2
  • If patient is taking α-glucosidase inhibitors, use ONLY glucose tablets or monosaccharides (not complex carbohydrates) 1, 3

Step 3: Monitoring and Repeat Dosing

  • Recheck blood glucose every 15 minutes until it stabilizes above 70 mg/dL 1, 3, 2
  • If blood glucose remains below 70 mg/dL after 15 minutes, repeat dextrose administration 3, 2
  • If using glucagon and no response after 15 minutes, administer an additional dose using a new kit while waiting for emergency assistance 4
  • Avoid overcorrection causing iatrogenic hyperglycemia by titrating dextrose carefully 3, 2

Step 4: Post-Recovery Management

  • Once the patient regains consciousness and can safely swallow, immediately give oral fast-acting carbohydrates (15-20 grams of glucose, regular soft drink, or fruit juice) 2
  • Follow with a meal or snack containing long-acting carbohydrates to restore liver glycogen and prevent recurrence 5, 2, 4

Critical Medication Management

  • Stop insulin infusions immediately if present—failing to do so will perpetuate hypoglycemia despite glucose replacement 1, 3
  • Hold or adjust doses of insulin, sulfonylureas, or meglitinides 1
  • Review all medications that may contribute to hypoglycemia 1

Glucagon Administration Details

Glucagon can and should be administered by family members and caregivers—it is not limited to healthcare professionals 5, 2, 4

Preparation and Dosing:

  • Using the supplied prefilled syringe, inject all liquid into the vial containing glucagon powder 4
  • Shake gently until completely dissolved and clear 4
  • The reconstituted solution is 1 mg per mL glucagon 4
  • Adults and children >25 kg or ≥6 years: 1 mg (1 mL) IM/SC 4
  • Children <25 kg or <6 years: 0.5 mg (0.5 mL) IM/SC 4
  • Call for emergency assistance immediately after administering 4

Comparative Efficacy: Recovery of consciousness after glucagon is slower than after IV dextrose (6.5 vs. 4.0 minutes), though both are effective 6

High-Risk Features Requiring Intensive Monitoring

Identify patients at increased risk for recurrent severe hypoglycemia: 1, 2

  • History of recurrent severe hypoglycemia or hypoglycemia unawareness
  • Concurrent illness, sepsis, hepatic failure, or renal failure
  • Recent reduction in corticosteroid dose or altered nutritional intake
  • Advanced age (>60 years)
  • Medications: insulin, sulfonylureas, or insulin secretagogues

Common Iatrogenic Triggers to Avoid

Hospital-related hypoglycemia is associated with higher mortality, so be vigilant for: 2

  • Sudden reduction of corticosteroid dose
  • Reduced oral intake, emesis, or new NPO status
  • Inappropriate timing of short-acting insulin in relation to meals
  • Reduced infusion rate of IV dextrose
  • Unexpected interruption of oral, enteral, or parenteral feedings

Post-Stabilization and Discharge Planning

Any episode of severe hypoglycemia requires reevaluation of the diabetes management plan 3, 2

Before Discharge:

  • Review and adjust medication regimen to prevent recurrence 1
  • Prescribe glucagon for home use and train family members/caregivers on administration 5, 1, 2
  • Educate patient and caregivers on recognizing early hypoglycemia symptoms 1, 2
  • Advise patient to always carry fast-acting glucose sources 5, 2
  • Recommend medical identification (bracelet/necklace) indicating diabetes and hypoglycemia risk 5, 2

For Patients with Hypoglycemia Unawareness:

  • Raise glycemic targets for at least several weeks to strictly avoid further hypoglycemia, which partially reverses hypoglycemia unawareness and reduces risk of future episodes 5, 3

Special Considerations for Sulfonylurea-Induced Hypoglycemia

Hypoglycemic coma due to sulfonylurea overdose always requires hospitalization for careful supervision and prolonged intravenous glucose infusion, as the duration of action is much longer than insulin 7

Target Blood Glucose Post-Treatment

  • Achieve blood glucose >70 mg/dL 1, 2
  • For hospitalized critically ill patients: maintain 140-180 mg/dL 2
  • For noncritically ill patients: target 100-180 mg/dL 2

References

Guideline

Immediate Management of Hypoglycemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Severe Hypoglycemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Refractory Hypoglycemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.